TY - JOUR
T1 - Gata2 19.5 enhancer regulates adult hematopoietic stem cell self-renewal and T-cell development
AU - You, Xiaona
AU - Zhou, Yun
AU - Chang, Yuan I.
AU - Kong, Guangyao
AU - Ranheim, Erik A.
AU - Johnson, Kirby D.
AU - Soukup, Alexandra A.
AU - Bresnick, Emery H.
AU - Zhang, Jing
N1 - Publisher Copyright:
© 2022 by The American Society of Hematology.
PY - 2022/2/22
Y1 - 2022/2/22
N2 - Mammalian GATA2 gene encodes a dual zinc finger transcription factor, which is essential for hematopoietic stem cell (HSC) generation in the aorta, gonad, mesonephros (AGM) region, HSC self-renewal, and specification of progenitor cell fates. Previously, we demonstrated that Gata2 expression in AGM is controlled by its intronic 19.5 enhancer. Gata2 19.5 deficiency removes the E-box motif and the GATA site and depletes fetal liver HSCs. However, whether this enhancer has an essential role in regulating adult hematopoiesis has not been established. Here, we evaluate Gata2 19.5 enhancer function in adult hematopoiesis. 19.51/2 bone marrow cells displayed reduced T cell reconstitution in a competitive transplant assay. Donor-derived analysis demonstrated a previously unrecognized function of the 19.5 enhancer in T cell development at the lymphoid-primed multipotent progenitor stage. Moreover, 19.51/2 adult HSCs displayed increased apoptosis and reduced long-term self-renewal capability in comparison with wild-type (WT) HSCs. These phenotypes were more moderate than those of Gata21/2 HSCs. Consistent with the phenotypic characterization, Gata2 expression in 19.51/2 LSKs was moderately higher than that in Gata21/2 LSKs, but lower than that in WT LSKs. Our data suggest that 19.5 deficiency compromises, without completely abrogating, Gata2 expression in adult HSCs.
AB - Mammalian GATA2 gene encodes a dual zinc finger transcription factor, which is essential for hematopoietic stem cell (HSC) generation in the aorta, gonad, mesonephros (AGM) region, HSC self-renewal, and specification of progenitor cell fates. Previously, we demonstrated that Gata2 expression in AGM is controlled by its intronic 19.5 enhancer. Gata2 19.5 deficiency removes the E-box motif and the GATA site and depletes fetal liver HSCs. However, whether this enhancer has an essential role in regulating adult hematopoiesis has not been established. Here, we evaluate Gata2 19.5 enhancer function in adult hematopoiesis. 19.51/2 bone marrow cells displayed reduced T cell reconstitution in a competitive transplant assay. Donor-derived analysis demonstrated a previously unrecognized function of the 19.5 enhancer in T cell development at the lymphoid-primed multipotent progenitor stage. Moreover, 19.51/2 adult HSCs displayed increased apoptosis and reduced long-term self-renewal capability in comparison with wild-type (WT) HSCs. These phenotypes were more moderate than those of Gata21/2 HSCs. Consistent with the phenotypic characterization, Gata2 expression in 19.51/2 LSKs was moderately higher than that in Gata21/2 LSKs, but lower than that in WT LSKs. Our data suggest that 19.5 deficiency compromises, without completely abrogating, Gata2 expression in adult HSCs.
UR - http://www.scopus.com/inward/record.url?scp=85125360882&partnerID=8YFLogxK
U2 - 10.1182/bloodadvances.2021004311
DO - 10.1182/bloodadvances.2021004311
M3 - Article
C2 - 34516632
AN - SCOPUS:85125360882
SN - 2473-9529
VL - 6
SP - 1095
EP - 1099
JO - Blood advances
JF - Blood advances
IS - 4
ER -